Sunday, March 22, 2015

Gene and cell therapy for neurogenetic disease: hope through research

Gene and cell therapy for neurogenetic disease: hope through research. INTERNATIONAL INNOVATION, Dr Marguerite Evans-Galea PhD, Murdoch Childrens Research Institute, Melbourne, Australia; Executive Member, Australasian Gene and Cell Therapy Society

AMELIORATION OF THE EFFECTS OF FRIEDRIECH'S ATAXIA .

AMELIORATION OF THE EFFECTS OF FRIEDRIECH'S ATAXIA. Applicants: WILSON, Robert, B., COTTICELLI, M., Grazia CRABBE, Andrew, M. Publication Date: 26.02.2015

The effects of Friedreich's Ataxia are ameliorated by administering to a patient known or suspected of having the disease with essentially free cis Δ9 fatty acid having from 12 to 24 carbon atoms and a single double bond in a cis configuration at the C9 carbon atom

Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications

Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications. Nadezda Apostolova and Victor M. Victor; Antioxid Redox Signal. 2015 March 10; 22(8): 686–729. doi: 10.1089/ars.2014.5952

FULL TEXT PDF Available in Europe PMC (Free)

A longitudinal study of the Friedreich Ataxia Impact Scale

A longitudinal study of the Friedreich Ataxia Impact Scale; Geneieve Tai, Eppie M. Yiu, Louise A. Corben, Martin B. Delatycki, Journal of the Neurological Sciences, Available online 21 March 2015, ISSN 0022-510X, http://dx.doi.org/10.1016/j.jns.2015.03.024.